Tutorials
DHA:SILCOPHL (Bangladesh)  
Silco Pharmaceuticals Ltd logo

Silco Pharmaceuticals Ltd

BDT 24.20 (-0.82%) Aug 11
P/E:
N/A
P/B:
0
Market Cap:
BDT - ($ -)
Enterprise V:
BDT - ($ -)
Volume:
253.49K
Avg Vol (2M):
679.67K
Volume:
253.49K
Market Cap BDT:
-
Market Cap $:
-
PE Ratio:
N/A
Avg Vol (2-Month):
679.67K
Enterprise Value BDT:
-
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Silco Pharmaceuticals Ltd
41, Nurani, Bankolapara, Subidbazar, Sylhet, BGD, 3100
Compare
Compare
Traded in other countries / regions
SILCOPHL.Bangladesh
Description
Silco Pharmaceuticals Ltd is engaged in manufacturing and marketing of pharmaceuticals finished products in the categories of Antibiotics, Analgesics, Anti diabetics, Narcotics, Antipyratics, Anti-inflammatory Drugs, Antiulcerants, Multi medicines which are sold mainly in local market.
Name Current Vs Industry Vs History
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 41.92
9-Day RSI 44.82
14-Day RSI 44.24
6-1 Month Momentum % -0.38
12-1 Month Momentum % -21.62

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History
Dividend Yield % 4.13
Forward Dividend Yield % 4.13
5-Year Yield-on-Cost % 4.13
Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History
PE Ratio N/A
N/A
N/A
PE Ratio without NRI N/A
N/A
N/A
PS Ratio 192.19

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil BDT) 0
EPS (TTM) (BDT) 0
Beta 0
Volatility % 27.1
14-Day RSI 44.24
14-Day ATR (BDT) 0.828674
20-Day SMA (BDT) 24.275
12-1 Month Momentum % -21.62
52-Week Range (BDT) 22.1 - 35.5
Shares Outstanding (Mil) 0

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Silco Pharmaceuticals Ltd Filings

Document Form Filing Date
No Filing Data